A 62-year-old man presented with complaints of dysphagia to solids and liquids, a globus sensation, and dysphonia. He recently had undergone emergent surgery via a right anterior cervical approach for cervical fusion. After surgery he noted an increased effort to swallow, without aspiration. Flexible nasolaryngoscopy revealed right vocal fold hypomobility with complete glottic closure, vocal fold atrophy, and edema of the posterior pharyngeal wall.
Lyndsay L. Madden, DO; Roxann Diez Gross, PhD; Libby J. Smith, DO A 62-year-old man presented with complaints of dysphagia to solids and liquids, a globus sensation, and dysphonia. He recently had undergone emergent surgery via a right anterior cervical approach for cervical fusion. After surgery he noted an increased effort to swallow, without aspiration. Flexible nasolaryngoscopy revealed right vocal fold hypomobility with complete glottic closure, vocal fold atrophy, and edema of the posterior pharyngeal wall.
The patient completed a modified barium swallow study, which showed an "odd" trajectory of the hyoid with hyolaryngeal elevation during the swallow. Computed tomography (CT) of the neck with 3-dimensional reconstruction images was then obtained, which indi- cated that the patient had bilateral calcified stylohyoid ligaments to the level of the hyoid bone, with no other pathologic findings (figures 1 and 2).
The patient was treated with swallowing therapy with resolution of swallowing function. However, in further discussion he reported long-term mild dysphagia complaints likely related to Eagle syndrome.
Eagle Syndrome was first described in 1937 by Eagle as elongation of the styloid process causing pharyngeal pain, 1 and it is now thought to be an assemblage of symptoms resulting from elongation of the styloid process or progressive calcification of the stylohyoid ligament. 2 Patients with Eagle syndrome often report symptoms that include dysphagia, otalgia, throat pain, ENT-Ear, Nose & Throat Journal  February 2015
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Microscopic examination demonstrated an aggregation of thin-walled capillaries in a lobulated pattern, confirming a diagnosis of pyogenic granuloma. The patient had no recurrence of the lesion for 15 months.
Pyogenic granuloma (lobular capillary hemangioma) is a benign, exophytic, vascular tumor, described in 1897 by Poncet and Dor as botryomycosis hominis. 1 Mucosal lesions have a tendency to occur in young adults and pregnant women. [1] [2] [3] [4] The most common sites are areas rich in blood supply that are vulnerable to trauma, with a striking predilection for the gingiva. [1] [2] [3] [4] [5] [6] Although the exact pathogenesis of pyogenic granuloma is not clearly established, the lesion has been hypothesized to be a reactive process followed by an impaired wound healing response. 5 Imbalance between angiogenesis enhancers and inhibitors, as well as hormone changes, have been considered as essential factors in the development of this lesion. 5, 6 The differential diagnosis should include hemangioma, bacillary angiomatosis, peripheral giant cell granuloma, peripheral ossifying fibroma, and some malignancies, such as Kaposi sarcoma, squamous cell carcinoma, and achromic melanoma.
Conservative surgical excision, cryotherapy, pulseddye laser therapy, and CO 2 laser therapy are all effective treatments. [1] [2] [3] Prevention depends on eliminating sources of repeated microtrauma. 1, 4 globus sensation, facial pain, headache, taste disturbances, and dental pain 2 that worsen with chewing, head and tongue movements, and swallowing. 3 This syndrome has been discussed in current literature to be caused by soft-tissue trauma, genetics, or an anatomic variant. 2, 3 The diagnosis of Eagle Syndrome is one of exclusion, and it can be confirmed on panoramic radiographs, lateral cervical films, or CT. 4 Recent evidence suggests that the use of 3-dimensional CT may serve as a valuable tool in surgical planning. 5 There are few treatment options available for Eagle syndrome, including dysphagia therapy and pharmacotherapy with anti-inflammatory drugs and/or steroid injections. 2 In patients with moderate to severe symptoms, surgical intervention is the definitive treatment. 
